EpiCept Corporation’s Board of Directors Appoints New Independent Member

April 28, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today the appointment of Keith L. Brownlie, former partner of Ernst & Young LLP, to its Board of Directors.

Twitter
LinkedIn
Facebook
Email
Print

People